Mast cell inflammasome activity in the meninges regulates EAE disease severity

Clinical Immunology

Volumn 189, Issue , 2018, Pages 14-22

  Russi, Abigail E ^a,c   Walker Caulfield, Margaret E ^b   Brown, Melissa A ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b MAYO CLINIC   (United States)

^c Interdisciplinary Scientist Training Program   (United States)

Author keywords

CNS demyelinating disease; EAE; GM CSF; IL 1 ; Inflammasome; Mast cells; Meninges; Multiple sclerosis; T cell pathogenicity

Indexed keywords

CYTOKINE RECEPTOR ANTAGONIST; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INFLAMMASOME; INTERLEUKIN 1BETA; MYELIN;

ARTICLE; BRAIN; CELL ACTIVITY; CELL INFILTRATION; CELL INTERACTION; CENTRAL NERVOUS SYSTEM; DISEASE EXACERBATION; DISEASE SEVERITY; ENCEPHALOMYELITIS; HUMAN; MAST CELL; MENINX; MULTIPLE SCLEROSIS; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; SPINAL CORD; STAGING; T LYMPHOCYTE; ANIMAL; CELL COMMUNICATION; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; IMMUNOLOGY; INFLAMMATION; METABOLISM;

ANIMALS; CELL COMMUNICATION; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; HUMANS; INFLAMMASOMES; INFLAMMATION; MAST CELLS; MENINGES; MULTIPLE SCLEROSIS; T-LYMPHOCYTES;

EID: 84975770187     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2016.04.009     Document Type: Article

References (93)

1. Hauser, S.L., Oksenberg, J.R., The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration. Neuron 52 (2006), 61–76.
2. Nylander, A., Hafler, D.A., Multiple sclerosis. J. Clin. Invest. 122 (2012), 1180–1188.
3. Rangachari, M., Kuchroo, V.K., Using EAE to better understand principles of immune function and autoimmune pathology. J. Autoimmun. 45 (2013), 31–39.
4. Codarri, L., Greter, M., Becher, B., Communication between pathogenic T cells and myeloid cells in neuroinflammatory disease. Trends Immunol. 34 (2013), 114–119.
5. Lee, Y., Awasthi, A., Yosef, N., Quintana, F.J., Xiao, S., Peters, A., Wu, C., Kleinewietfeld, M., Kunder, S., Hafler, D.A., Sobel, R.A., Regev, A., Kuchroo, V.K., Induction and molecular signature of pathogenic TH17 cells. Nat. Immunol. 13 (2012), 991–999.
6. El-Behi, M., Ciric, B., Dai, H., Yan, Y., Cullimore, M., Safavi, F., Zhang, G.X., Dittel, B.N., Rostami, A., The encephalitogenicity of T(H)17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF. Nat. Immunol. 12 (2011), 568–575.
7. Croxford, A.L., Lanzinger, M., Hartmann, F.J., Schreiner, B., Mair, F., Pelczar, P., Clausen, B.E., Jung, S., Greter, M., Becher, B., The cytokine GM-CSF drives the inflammatory signature of CCR2 + monocytes and licenses autoimmunity. Immunity 43 (2015), 502–514.
8. Dinarello, C.A., Interleukin-1beta and the autoinflammatory diseases. N. Engl. J. Med. 360 (2009), 2467–2470.
9. Dinarello, C.A., Immunological and inflammatory functions of the interleukin-1 family. Annu. Rev. Immunol. 27 (2009), 519–550.
10. Lukens, J.R., Barr, M.J., Chaplin, D.D., Chi, H., Kanneganti, T.D., Inflammasome-derived IL-1beta regulates the production of GM-CSF by CD4(+) T cells and gammadelta T cells. J. Immunol. 188 (2012), 3107–3115.
11. Khare, S., Luc, N., Dorfleutner, A., Stehlik, C., Inflammasomes and their activation. Crit. Rev. Immunol. 30 (2010), 463–487.
12. B.N. Martin, C. Wang, C.J. Zhang, Z. Kang, M.F. Gulen, J.A. Zepp, J. Zhao, G. Bian, J.S. Do, B. Min, P.G. Pavicic, Jr., C. El-Sanadi, P.L. Fox, A. Akitsu, Y. Iwakura, A. Sarkar, M.D. Wewers, W.J. Kaiser, E.S. Mocarski, M.E. Rothenberg, A.G. Hise, G.R. Dubyak, R.M. Ransohoff, X. Li, T cell-intrinsic ASC critically promotes T17-mediated experimental autoimmune encephalomyelitis, Nat. Immunol., 2016 (epub).
13. Nakamura, Y., Franchi, L., Kambe, N., Meng, G., Strober, W., Nunez, G., Critical role for mast cells in interleukin-1beta-driven skin inflammation associated with an activating mutation in the nlrp3 protein. Immunity 37 (2012), 85–95.
14. Nakamura, Y., Kambe, N., Saito, M., Nishikomori, R., Kim, Y.G., Murakami, M., Nunez, G., Matsue, H., Mast cells mediate neutrophil recruitment and vascular leakage through the NLRP3 inflammasome in histamine-independent urticaria. J. Exp. Med. 206 (2009), 1037–1046.
15. Hoffman, H.M., Mueller, J.L., Broide, D.H., Wanderer, A.A., Kolodner, R.D., Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nat. Genet. 29 (2001), 301–305.
16. Russi, A.E., Brown, M.A., The meninges: new therapeutic targets for multiple sclerosis. Transl. Res. 165 (2015), 255–269.
17. Patel, N., Kirmi, O., Anatomy and imaging of the normal meninges. Semin. Ultrasound CT MR 30 (2009), 559–564.
18. Hatfield, J.K., Brown, M.A., Group 3 innate lymphoid cells accumulate and exhibit disease-induced activation in the meninges in EAE. Cell. Immunol. 297 (2015), 69–79.
19. Walker-Caulfield, M.E., Hatfield, J.K., Brown, M.A., Dynamic changes in meningeal inflammation correspond to clinical exacerbations in a murine model of relapsing-remitting multiple sclerosis. J. Neuroimmunol. 278 (2015), 112–122.
20. Reboldi, A., Coisne, C., Baumjohann, D., Benvenuto, F., Bottinelli, D., Lira, S., Uccelli, A., Lanzavecchia, A., Engelhardt, B., Sallusto, F., C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE. Nat. Immunol. 10 (2009), 514–523.
21. Ransohoff, R.M., Immunology: in the beginning. Nature 462 (2009), 41–42.
22. Ransohoff, R.M., Engelhardt, B., The anatomical and cellular basis of immune surveillance in the central nervous system. Nat. Rev. Immunol. 12 (2012), 623–635.
23. Bartholomaus, I., Kawakami, N., Odoardi, F., Schlager, C., Miljkovic, D., Ellwart, J.W., Klinkert, W.E., Flugel-Koch, C., Issekutz, T.B., Wekerle, H., Flugel, A., Effector T cell interactions with meningeal vascular structures in nascent autoimmune CNS lesions. Nature 462 (2009), 94–98.
24. Kivisakk, P., Imitola, J., Rasmussen, S., Elyaman, W., Zhu, B., Ransohoff, R.M., Khoury, S.J., Localizing central nervous system immune surveillance: meningeal antigen-presenting cells activate T cells during experimental autoimmune encephalomyelitis. Ann. Neurol. 65 (2009), 457–469.
25. Kivisakk, P., Mahad, D.J., Callahan, M.K., Trebst, C., Tucky, B., Wei, T., Wu, L., Baekkevold, E.S., Lassmann, H., Staugaitis, S.M., Campbell, J.J., Ransohoff, R.M., Human cerebrospinal fluid central memory CD4 + T cells: evidence for trafficking through choroid plexus and meninges via P-selectin. Proc. Natl. Acad. Sci. U. S. A. 100 (2003), 8389–8394.
26. Kooi, E.J., van Horssen, J., Witte, M.E., Amor, S., Bo, L., Dijkstra, C.D., van der Valk, P., Geurts, J.J., Abundant extracellular myelin in the meninges of patients with multiple sclerosis. Neuropathol. Appl. Neurobiol. 35 (2009), 283–295.
27. Aloisi, F., Serafini, B., Magliozzi, R., Howell, O.W., Reynolds, R., Detection of Epstein-Barr virus and B-cell follicles in the multiple sclerosis brain: what you find depends on how and where you look. Brain, 133, 2010, e157.
28. Magliozzi, R., Columba-Cabezas, S., Serafini, B., Aloisi, F., Intracerebral expression of CXCL13 and BAFF is accompanied by formation of lymphoid follicle-like structures in the meninges of mice with relapsing experimental autoimmune encephalomyelitis. J. Neuroimmunol. 148 (2004), 11–23.
29. Magliozzi, R., Howell, O., Vora, A., Serafini, B., Nicholas, R., Puopolo, M., Reynolds, R., Aloisi, F., Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. Brain 130 (2007), 1089–1104.
30. Serafini, B., Rosicarelli, B., Magliozzi, R., Stigliano, E., Aloisi, F., Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis. Brain Pathol. 14 (2004), 164–174.
31. Lucchinetti, C.F., Popescu, B.F., Bunyan, R.F., Moll, N.M., Roemer, S.F., Lassmann, H., Bruck, W., Parisi, J.E., Scheithauer, B.W., Giannini, C., Weigand, S.D., Mandrekar, J., Ransohoff, R.M., Inflammatory cortical demyelination in early multiple sclerosis. N. Engl. J. Med. 365 (2011), 2188–2197.
32. Christy, A.L., Walker, M.E., Hessner, M.J., Brown, M.A., Mast cell activation and neutrophil recruitment promotes early and robust inflammation in the meninges in EAE. J. Autoimmun. 42 (2013), 50–61.
33. Axtell, R.C., Steinman, L., Gaining entry to an uninflamed brain. Nat. Immunol. 10 (2009), 453–455.
34. Sayed, B.A., Christy, A.L., Walker, M.E., Brown, M.A., Meningeal mast cells affect early T cell central nervous system infiltration and blood-brain barrier integrity through TNF: a role for neutrophil recruitment?. J. Immunol. 184 (2010), 6891–6900.
35. Galli, S.J., Tsai, M., Mast cells in allergy and infection: versatile effector and regulatory cells in innate and adaptive immunity. Eur. J. Immunol. 40 (2010), 1843–1851.
36. Tsai, M., Grimbaldeston, M., Galli, S.J., Mast cells and immunoregulation/immunomodulation. Adv. Exp. Med. Biol. 716 (2011), 186–211.
37. Rao, K.N., Brown, M.A., Mast cells: multifaceted immune cells with diverse roles in health and disease. Ann. N. Y. Acad. Sci. 1143 (2008), 83–104.
38. Ehrlich, P., Beitrage Zur Theorie and Praxis Der Histologischen Forbung. 1878, Leipzig University, Germany (Doctoral dissetation).
39. Galli, S.J., Tsai, M., Wershil, B.K., Tam, S.Y., Costa, J.J., Regulation of mouse and human mast cell development, survival and function by stem cell factor, the ligand for the c-kit receptor. Int. Arch. Allergy Immunol. 107 (1995), 51–53.
40. Graham, A.C., Temple, R.M., Obar, J.J., Mast cells and influenza a virus: association with allergic responses and beyond. Front. Immunol., 6, 2015, 238.
41. Graham, A.C., Hilmer, K.M., Zickovich, J.M., Obar, J.J., Inflammatory response of mast cells during influenza A virus infection is mediated by active infection and RIG-I signaling. J. Immunol. 190 (2013), 4676–4684.
42. Kambayashi, T., Baranski, J.D., Baker, R.G., Zou, T., Allenspach, E.J., Shoag, J.E., Jones, P.L., Koretzky, G.A., Indirect involvement of allergen-captured mast cells in antigen presentation. Blood 111 (2008), 1489–1496.
43. Malaviya, R., Twesten, N.J., Ross, E.A., Abraham, S.N., Pfeifer, J.D., Mast cells process bacterial Ags through a phagocytic route for class I MHC presentation to T cells. J. Immunol. 156 (1996), 1490–1496.
44. Kambayashi, T., Allenspach, E.J., Chang, J.T., Zou, T., Shoag, J.E., Reiner, S.L., Caton, A.J., Koretzky, G.A., Inducible MHC class II expression by mast cells supports effector and regulatory T cell activation. J. Immunol. 182 (2009), 4686–4695.
45. Merluzzi, S., Betto, E., Ceccaroni, A.A., Magris, R., Giunta, M., Mion, F., Mast cells, basophils and B cell connection network. Mol. Immunol. 63 (2015), 94–103.
46. Levy, D., Migraine pain, meningeal inflammation, and mast cells. Curr. Pain Headache Rep. 13 (2009), 237–240.
47. Galli, S.J., Tsai, M., Marichal, T., Tchougounova, E., Reber, L.L., Pejler, G., Approaches for analyzing the roles of mast cells and their proteases in vivo. Adv. Immunol. 126 (2015), 45–127.
48. Gaudenzio, N., Sibilano, R., Starkl, P., Tsai, M., Galli, S.J., Reber, L.L., Analyzing the functions of mast cells in vivo using ‘mast cell knock-in’ mice. J. Vis. Exp., 2015, e52753.
49. McNeil, B.D., Pundir, P., Meeker, S., Han, L., Undem, B.J., Kulka, M., Dong, X., Identification of a mast-cell-specific receptor crucial for pseudo-allergic drug reactions. Nature 519 (2015), 237–241.
50. Kitamura, Y., Go, S., Hatanaka, K., Decrease of mast cells in W/Wv mice and their increase by bone marrow transplantation. Blood 52 (1978), 447–452.
51. Piconese, S., Costanza, M., Musio, S., Tripodo, C., Poliani, P.L., Gri, G., Burocchi, A., Pittoni, P., Gorzanelli, A., Colombo, M.P., Pedotti, R., Exacerbated experimental autoimmune encephalomyelitis in mast-cell-deficient kit W-sh/W-sh mice. Lab. Investig. 91 (2011), 627–641.
52. Sayed, B.A., Walker, M.E., Brown, M.A., Cutting edge: mast cells regulate disease severity in a relapsing-remitting model of multiple sclerosis. J. Immunol. 186 (2011), 3294–3298.
53. Secor, V.H., Secor, W.E., Gutekunst, C.A., Brown, M.A., Mast cells are essential for early onset and severe disease in a murine model of multiple sclerosis. J. Exp. Med. 191 (2000), 813–822.
54. Tanzola, M.B., Robbie-Ryan, M., Gutekunst, C.A., Brown, M.A., Mast cells exert effects outside the central nervous system to influence experimental allergic encephalomyelitis disease course. J. Immunol. 171 (2003), 4385–4391.
55. Ibrahim, M.Z., Reder, A.T., Lawand, R., Takash, W., Sallouh-Khatib, S., The mast cells of the multiple sclerosis brain. J. Neuroimmunol. 70 (1996), 131–138.
56. Rozniecki, J.J., Hauser, S.L., Stein, M., Lincoln, R., Theoharides, T.C., Elevated mast cell tryptase in cerebrospinal fluid of multiple sclerosis patients. Ann. Neurol. 37 (1995), 63–66.
57. Lock, C., Hermans, G., Pedotti, R., Brendolan, A., Schadt, E., Garren, H., Langer-Gould, A., Strober, S., Cannella, B., Allard, J., Klonowski, P., Austin, A., Lad, N., Kaminski, N., Galli, S.J., Oksenberg, J.R., Raine, C.S., Heller, R., Steinman, L., Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat. Med. 8 (2002), 500–508.
58. Zhao, R., Zhou, H., Su, S.B., A critical role for interleukin-1beta in the progression of autoimmune diseases. Int. Immunopharmacol. 17 (2013), 658–669.
59. Shao, B.Z., Xu, Z.Q., Han, B.Z., Su, D.F., Liu, C., NLRP3 inflammasome and its inhibitors: a review. Front. Pharmacol., 6, 2015, 262.
60. Freeman, L.C., Ting, J.P., The pathogenic role of the inflammasome in neurodegenerative diseases. J. Neurochem., 2015.
61. Balashov, K.E., Rottman, J.B., Weiner, H.L., Hancock, W.W., CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions. Proc. Natl. Acad. Sci. U. S. A. 96 (1999), 6873–6878.
62. Karni, A., Koldzic, D.N., Bharanidharan, P., Khoury, S.J., Weiner, H.L., IL-18 is linked to raised IFN-gamma in multiple sclerosis and is induced by activated CD4(+) T cells via CD40-CD40 ligand interactions. J. Neuroimmunol. 125 (2002), 134–140.
63. Losy, J., Niezgoda, A., IL-18 in patients with multiple sclerosis. Acta Neurol. Scand. 104 (2001), 171–173.
64. Mann, C.L., Davies, M.B., Stevenson, V.L., Leary, S.M., Boggild, M.D., Ko Ko, C., Jones, P.W., Fryer, A.A., Strange, R.C., Thompson, A.J., Hawkins, C.P., Interleukin 1 genotypes in multiple sclerosis and relationship to disease severity. J. Neuroimmunol. 129 (2002), 197–204.
65. Peelen, E., Damoiseaux, J., Muris, A.H., Knippenberg, S., Smolders, J., Hupperts, R., Thewissen, M., Increased inflammasome related gene expression profile in PBMC may facilitate T helper 17 cell induction in multiple sclerosis. Mol. Immunol. 63 (2015), 521–529.
66. Furlan, R., Filippi, M., Bergami, A., Rocca, M.A., Martinelli, V., Poliani, P.L., Grimaldi, L.M., Desina, G., Comi, G., Martino, G., Peripheral levels of caspase-1 mRNA correlate with disease activity in patients with multiple sclerosis; a preliminary study. J. Neurol. Neurosurg. Psychiatry 67 (1999), 785–788.
67. Ming, X., Li, W., Maeda, Y., Blumberg, B., Raval, S., Cook, S.D., Dowling, P.C., Caspase-1 expression in multiple sclerosis plaques and cultured glial cells. J. Neurol. Sci. 197 (2002), 9–18.
68. de Jong, B.A., Huizinga, T.W., Bollen, E.L., Uitdehaag, B.M., Bosma, G.P., van Buchem, M.A., Remarque, E.J., Burgmans, A.C., Kalkers, N.F., Polman, C.H., Westendorp, R.G., Production of IL-1beta and IL-1Ra as risk factors for susceptibility and progression of relapse-onset multiple sclerosis. J. Neuroimmunol. 126 (2002), 172–179.
69. Feakes, R., Sawcer, S., Broadley, S., Coraddu, F., Roxburgh, R., Gray, J., Clayton, D., Compston, A., Interleukin 1 receptor antagonist (IL-1ra) in multiple sclerosis. J. Neuroimmunol. 105 (2000), 96–101.
70. Gris, D., Ye, Z., Iocca, H.A., Wen, H., Craven, R.R., Gris, P., Huang, M., Schneider, M., Miller, S.D., Ting, J.P., NLRP3 plays a critical role in the development of experimental autoimmune encephalomyelitis by mediating Th1 and Th17 responses. J. Immunol. 185 (2010), 974–981.
71. Furlan, R., Martino, G., Galbiati, F., Poliani, P.L., Smiroldo, S., Bergami, A., Desina, G., Comi, G., Flavell, R., Su, M.S., Adorini, L., Caspase-1 regulates the inflammatory process leading to autoimmune demyelination. J. Immunol. 163 (1999), 2403–2409.
72. Inoue, M., Williams, K.L., Oliver, T., Vandenabeele, P., Rajan, J.V., Miao, E.A., Shinohara, M.L., Interferon-beta therapy against EAE is effective only when development of the disease depends on the NLRP3 inflammasome. Sci. Signal., 5, 2012, ra38.
73. Jha, S., Srivastava, S.Y., Brickey, W.J., Iocca, H., Toews, A., Morrison, J.P., Chen, V.S., Gris, D., Matsushima, G.K., Ting, J.P., The inflammasome sensor, NLRP3, regulates CNS inflammation and demyelination via caspase-1 and interleukin-18. J. Neurosci. 30 (2010), 15811–15820.
74. Inoue, M., Williams, K.L., Gunn, M.D., Shinohara, M.L., NLRP3 inflammasome induces chemotactic immune cell migration to the CNS in experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. U. S. A. 109 (2012), 10480–10485.
75. Sena, L.A., Li, S., Jairaman, A., Prakriya, M., Ezponda, T., Hildeman, D.A., Wang, C.R., Schumacker, P.T., Licht, J.D., Perlman, H., Bryce, P.J., Chandel, N.S., Mitochondria are required for antigen-specific T cell activation through reactive oxygen species signaling. Immunity 38 (2013), 225–236.
76. Finkel, T., Signal transduction by mitochondrial oxidants. J. Biol. Chem. 287 (2012), 4434–4440.
77. Gri, G., Piconese, S., Frossi, B., Manfroi, V., Merluzzi, S., Tripodo, C., Viola, A., Odom, S., Rivera, J., Colombo, M.P., Pucillo, C.E., CD4 + CD25 + regulatory T cells suppress mast cell degranulation and allergic responses through OX40-OX40L interaction. Immunity 29 (2008), 771–781.
78. Inamura, N., Mekori, Y.A., Bhattacharyya, S.P., Bianchine, P.J., Metcalfe, D.D., Induction and enhancement of Fc(epsilon)RI-dependent mast cell degranulation following coculture with activated T cells: dependency on ICAM-1- and leukocyte function-associated antigen (LFA)-1-mediated heterotypic aggregation. J. Immunol. 160 (1998), 4026–4033.
79. Piconese, S., Gri, G., Tripodo, C., Musio, S., Gorzanelli, A., Frossi, B., Pedotti, R., Pucillo, C.E., Colombo, M.P., Mast cells counteract regulatory T-cell suppression through interleukin-6 and OX40/OX40L axis toward Th17-cell differentiation. Blood 114 (2009), 2639–2648.
80. Dinarello, C.A., Simon, A., van der Meer, J.W., Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases. Nat. Rev. Drug Discov. 11 (2012), 633–652.
81. Badovinac, V., Mostarica-Stojkovic, M., Dinarello, C.A., Stosic-Grujicic, S., Interleukin-1 receptor antagonist suppresses experimental autoimmune encephalomyelitis (EAE) in rats by influencing the activation and proliferation of encephalitogenic cells. J. Neuroimmunol. 85 (1998), 87–95.
82. Youm, Y.H., Nguyen, K.Y., Grant, R.W., Goldberg, E.L., Bodogai, M., Kim, D., D'Agostino, D., Planavsky, N., Lupfer, C., Kanneganti, T.D., Kang, S., Horvath, T.L., Fahmy, T.M., Crawford, P.A., Biragyn, A., Alnemri, E., Dixit, V.D., The ketone metabolite beta-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease. Nat. Med. 21 (2015), 263–269.
83. Coll, R.C., Robertson, A.A., Chae, J.J., Higgins, S.C., Munoz-Planillo, R., Inserra, M.C., Vetter, I., Dungan, L.S., Monks, B.G., Stutz, A., Croker, D.E., Butler, M.S., Haneklaus, M., Sutton, C.E., Nunez, G., Latz, E., Kastner, D.L., Mills, K.H., Masters, S.L., Schroder, K., Cooper, M.A., O'Neill, L.A., A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases. Nat. Med. 21 (2015), 248–255.
84. Smoum, R., Baraghithy, S., Chourasia, M., Breuer, A., Mussai, N., Attar-Namdar, M., Kogan, N.M., Raphael, B., Bolognini, D., Cascio, M.G., Marini, P., Pertwee, R.G., Shurki, A., Mechoulam, R., Bab, I., CB2 cannabinoid receptor agonist enantiomers HU-433 and HU-308: an inverse relationship between binding affinity and biological potency. Proc. Natl. Acad. Sci. U. S. A. 112 (2015), 8774–8779.
85. Shao, B.Z., Wei, W., Ke, P., Xu, Z.Q., Zhou, J.X., Liu, C., Activating cannabinoid receptor 2 alleviates pathogenesis of experimental autoimmune encephalomyelitis via activation of autophagy and inhibiting NLRP3 inflammasome. CNS Neurosci. Ther. 20 (2014), 1021–1028.
86. Carpintero, R., Burger, D., IFNbeta and glatiramer acetate trigger different signaling pathways to regulate the IL-1 system in multiple sclerosis. Commun. Integr. Biol. 4 (2011), 112–114.
87. Nicoletti, F., Patti, F., DiMarco, R., Zaccone, P., Nicoletti, A., Meroni, P., Reggio, A., Circulating serum levels of IL-1ra in patients with relapsing remitting multiple sclerosis are normal during remission phases but significantly increased either during exacerbations or in response to IFN-beta treatment. Cytokine 8 (1996), 395–400.
88. Caragnano, M., Tortorella, P., Bergami, A., Ruggieri, M., Livrea, P., Specchio, L.M., Martino, G., Trojano, M., Furlan, R., Avolio, C., Monocytes P2X7 purinergic receptor is modulated by glatiramer acetate in multiple sclerosis. J. Neuroimmunol. 245 (2012), 93–97.
89. Guarda, G., Braun, M., Staehli, F., Tardivel, A., Mattmann, C., Forster, I., Farlik, M., Decker, T., Pasquier, R.A.D., Romero, P., Tschopp, J., Type I interferon inhibits interleukin-1 production and inflammasome activation. Immunity 34 (2011), 213–223.
90. Wang, Q., Chuikov, S., Taitano, S., Wu, Q., Rastogi, A., Tuck, S.J., Corey, J.M., Lundy, S.K., Mao-Draayer, Y., Dimethyl fumarate protects neural stem/progenitor cells and neurons from oxidative damage through Nrf2-ERK1/2 MAPK pathway. Int. J. Mol. Sci. 16 (2015), 13885–13907.
91. Malhotra, S., Rio, J., Urcelay, E., Nurtdinov, R., Bustamante, M.F., Fernandez, O., Oliver, B., Zettl, U., Brassat, D., Killestein, J., Lechner-Scott, J., Drulovic, J., Chan, A., Martinelli-Boneschi, F., Garcia-Merino, A., Montalban, X., Comabella, M., NLRP3 inflammasome is associated with the response to IFN-beta in patients with multiple sclerosis. Brain 138 (2015), 644–652.
92. Odoardi, F., Sie, C., Streyl, K., Ulaganathan, V.K., Schlager, C., Lodygin, D., Heckelsmiller, K., Nietfeld, W., Ellwart, J., Klinkert, W.E., Lottaz, C., Nosov, M., Brinkmann, V., Spang, R., Lehrach, H., Vingron, M., Wekerle, H., Flugel-Koch, C., Flugel, A., T cells become licensed in the lung to enter the central nervous system. Nature 488 (2012), 675–679.
93. Berer, K., Mues, M., Koutrolos, M., Rasbi, Z.A., Boziki, M., Johner, C., Wekerle, H., Krishnamoorthy, G., Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination. Nature 479 (2011), 538–541.